MedCity Update – April 2018
To view this email in a web browser, go here
MedCity

Welcome – Sarah Haywood, CEO, MedCity

We are officially four years old this month and we have come a long way in that time. From the events and missions we have led and supported, to creating and building our angel investing and SME-academic programmes, to helping international companies set up in the Golden Triangle and boosting entrepreneurship coming out of our universities – we have achieved a great deal; but there is always more we can do and we welcome feedback on what we could be doing differently. I would just like to say a big thank you to everyone who has supported us to build our cluster organisation – and we will celebrate our 5th birthday in style in 2019!

It has been a busy few weeks in relation to our work to support the entrepreneurial ecosystem. Many of the team contributed to DigitalHealth.London’s Collaborate event focused on Digital Therapeutics last Tuesday. There are lots of take away points for us to work on and continue to assist companies to generate evidence to get their products to market. We also attended the launch of a new healthtech accelerator programme, HS., this month, which is working with 30 people to build and scale their companies. Take a look at them here. Finally, I had an early start on Saturday when I supported and spoke at the Panacea Stars bootcamp, hosted at Lady Margaret Hall in Oxford.

East London Genes and Health held an industry workshop last Monday, where we had a tour of the Clinical Research Facility and heard from Prof David Van Heel and Prof Richard Trembath about the ambitions of the projects and the opportunities for industry to engage. If you want to learn more about this genomics programme, look them up at genesandhealth.org – this project also features in our report on genomics within the region, which you can find at genomicsuk.com.

We are heading to BIO US in Boston from 4 – 7 June, alongside London & Partners, and will be part of the Department for International Trade stand. Please get in touch with Prasshy or find us on the partnering platform, if you would like to meet up whilst we are there. We also have London Tech Week coming up – take a look below for how to be a part of the flagship HealthTech Innovators Conference.

As I’m sure most of you are aware, the new data protection regulations – GDPR – are coming in on 25 May and we would like you to confirm your subscription to our monthly newsletter. If you want to continue receiving our monthly news, events and opportunities just confirm here.

And finally, welcome to our new Market Analyst, Christina Papadaki, who joins us following her PhD in Neuropsychology at UCL. You can get in touch with her at christinapapadaki@medcityhq.com

MedCity’s Company of the Month

This month we spoke to Sumit Jamuar, CEO at Global Gene Corp, a Cambridge company that aims to democratise healthcare through genomics and are well known for their work in mapping genetic data from the population of South Asia.

Read the Q & A

Sumit Jamuar
GDPR

We don’t want to lose you!

The rules around personal data are changing. If you want to continue to receive our monthly newsletter, please give your consent before 24 May. Opting in is simple – just click below and provide your name & email address. We do not need any additional information and you can, of course, unsubscribe at any time.

Keep receiving MedCity newsletters

HealthTech Innovators Conference

We’re working with Tech London Advocates HealthTech Group and Health Foundry on a flagship healthtech event on 12 June, for London Tech Week. We are inviting innovators, investors and industry to come together to see the best of London’s digital health ecosystem. For a chance to be a part of it – on the marketplace or as a guest – click below.

 Find out more

GDPR
Catapult Stevenage

New £60m cell and gene therapy centre for Stevenage

The Cell and Gene Therapy Catapult’s new manufacturing centre, which could help advance the treatment of paralysis, blindness and Alzheimer’s disease, was officially opened by Business Secretary Greg Clark and Science Minister Sam Gyimah last week.

Find out more

Join us on our Japan Mission

We are heading to Japan and Korea in October for the annual BioJapan conference and are inviting companies, academics and partners to join our delegation. Take a look at our offer and get in touch if you’re interested.

 Find out more

Japan
Blue Earth DX

Blue Earth Diagnostics opens new Oxford HQ

The leading molecular imaging diagnostics company has expanded its global HQ at Oxford Science Park. The new offices will employ over 20 scientists, physicians and support staff to drive the development of new technologies for molecular imaging in diseases such as glioma and prostate cancer.

Find out more 

‘Killer’ kidney cancers identified by studying their evolution

Scientists at The Francis Crick Institute have discovered that kidney cancer follows distinct evolutionary paths, enabling them to detect whether a tumour will be aggressive and revealing that the first seeds of kidney cancer are sown as early as childhood.

Find out more 

The Crick
DigitalHealth.London

DH.L/ Collaborate  

Providers, clinicians, SMEs and policy makers all came together on Tuesday, for an event hosted by DigitalHealth.London and IQVIA, looking at Digital Therapeutics and the challenges and support for evidence generation. Take a look at some of the highlights from the Summit.

Click here

DigitalHealth.London

Expert Reviewers needed

The digital health accelerators being run by DigitalHealth.London, East Midlands AHSN, South West AHSN, Health Innovation Manchester, and Kent Surrey and Sussex AHSN are looking for “expert reviewers” to support the assessment of applications.

Find out more

Events 

Launched in April 2014, MedCity is a collaboration between the Mayor of London, Imperial College Academic Health Science Centre, King’s Health Partners, UCL Partners, Cambridge University Health Partners and Oxford Academic Health Science Centre. 

The next edition of MedCity Update will be sent in May 2018.